Increased induction of de novo serum ANCA and ANCA-associated vasculitis after mass vaccination against SARS-CoV-2
Summary: Different immune-mediated diseases have been described after SARS-CoV-2 vaccination, with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV) being one of the possible side effects. In this study, a total of 35 patients presented ANCA for the first time during 2021, wit...
Main Authors: | Juan Irure-Ventura, Lara Belmar-Vega, Gema Fernández-Fresnedo, Elena González-López, Carolina Castro-Hernández, Emilio Rodrigo-Calabia, Milagros Heras-Vicario, Juan Carlos Ruiz San Millán, Marcos López-Hoyos |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-08-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004222011191 |
Similar Items
-
Non-Criteria Antiphospholipid Antibodies: Risk Factors for Endothelial Dysfunction in Women with Pre-Eclampsia
by: Lara Belmar Vega, et al.
Published: (2020-10-01) -
Immunopathogenesis of ANCA-Associated Vasculitis
by: Andreas Kronbichler, et al.
Published: (2020-10-01) -
ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01) -
Updates in ANCA-associated vasculitis
by: Carolyn Ross, et al.
Published: (2022-07-01) -
Explaining fatigue in ANCA-associated vasculitis
by: Basu, N, et al.
Published: (2013)